礼来公司诉基因泰克公司案

{"title":"礼来公司诉基因泰克公司案","authors":"","doi":"10.1093/rpc/rcab016","DOIUrl":null,"url":null,"abstract":"\n H1 European patents – Revocation proceedings – Divisional Patents – Pharmaceuticals –Preliminary issue – Summary judgment - Issue estoppel – Abuse of process – UK designation of closely related patent held invalid at first instance – Permission granted to appeal to the Court of Appeal - Related patent now also held invalid in central proceedings before the EPO – Special circumstances – Injustice – Application to amend claims – Plausibility – Changes in common general knowledge – Case management","PeriodicalId":336842,"journal":{"name":"Reports of Patent, Design and Trade Mark Cases","volume":"124 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Eli Lilly and CO v Genentech, Inc\",\"authors\":\"\",\"doi\":\"10.1093/rpc/rcab016\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n H1 European patents – Revocation proceedings – Divisional Patents – Pharmaceuticals –Preliminary issue – Summary judgment - Issue estoppel – Abuse of process – UK designation of closely related patent held invalid at first instance – Permission granted to appeal to the Court of Appeal - Related patent now also held invalid in central proceedings before the EPO – Special circumstances – Injustice – Application to amend claims – Plausibility – Changes in common general knowledge – Case management\",\"PeriodicalId\":336842,\"journal\":{\"name\":\"Reports of Patent, Design and Trade Mark Cases\",\"volume\":\"124 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-09-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reports of Patent, Design and Trade Mark Cases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/rpc/rcab016\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reports of Patent, Design and Trade Mark Cases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/rpc/rcab016","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

H1欧洲专利撤销诉讼-部门专利药品的初步问题——即决判决问题禁止滥用过程——英国指定密切相关的专利无效的在第一个实例——上诉获准上诉法院相关专利现在还持有无效诉讼前中部EPO -特殊情况不公正——应用程序修改索赔合理性——常见的一般知识的变化——案例管理
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Eli Lilly and CO v Genentech, Inc
H1 European patents – Revocation proceedings – Divisional Patents – Pharmaceuticals –Preliminary issue – Summary judgment - Issue estoppel – Abuse of process – UK designation of closely related patent held invalid at first instance – Permission granted to appeal to the Court of Appeal - Related patent now also held invalid in central proceedings before the EPO – Special circumstances – Injustice – Application to amend claims – Plausibility – Changes in common general knowledge – Case management
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信